CAPE CANAVERAL, Fla.--(BUSINESS WIRE)--Peer Ledger, a Canadian blockchain company, has become a vendor partner of SAFE-BioPharma Association, LLC.
The blockchain technology offered by Peer Ledger has many applications across the healthcare industry. It is critical that the biopharmaceutical and healthcare industries have a high degree of trust in the identity of individuals with whom they are conducting electronic business transactions.
A proof of concept, using Peer Ledger’s Identity Bridge in 2017, demonstrated that SAFE-BioPharma compliant digital identities can be associated with a blockchain to assure trust in the identity of each person engaged in the transaction.
SAFE-BioPharma Association was established to provide global, high-assurance identity trust for cyber-transactions. The SAFE-BioPharma® digital identity and signature standards were crafted to mitigate risk associated with electronic transactions by protecting intellectual property and patient data using secure, enforceable, and regulatory compliant mechanisms. The standards are widely used within the global clinical trials industry.
The Identity Bridge provides immediate benefit for clinical trials by enabling de-anonymization of blockchain identities, which fulfills a requirement for double-blinds, audits, and responsible supply chains. There are also significant opportunities to apply this technology across the healthcare industry in regulated use cases requiring high degrees of identity trust.
“As we continue to look for opportunities to expand the use of our standards, leveraging SAFE-BioPharma compliant identity credentials with emerging blockchain technologies is an exciting approach to help protect patient privacy, enhance health transaction security, and contribute to patient safety,” explains Matt King, Director of SAFE-BioPharma.
About Peer Ledger
Peer Ledger [www.peerledger.com] is a blockchain company specializing in the pharmaceutical, healthcare, mineral, and agricultural sectors. It offers an identity bridge product between public key infrastructure and blockchain, and the MIMOSI track-and-trace blockchain product for responsible supply chains.
About SAFE-BioPharma Association, LLC
As part of the National Health Information Sharing and Analysis Center (NH-ISAC), SAFE-BioPharma Association, LLC [www.safe-biopharma.org] provides global, high-assurance identity trust for cyber-transactions in the biopharmaceutical and healthcare industries.
The SAFE-BioPharma® digital identity and signature standards were crafted to mitigate risk associated with electronic transactions by protecting intellectual property and patient data using secure, enforceable, and regulatory compliant mechanisms.
SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Use of this trademark requires approval from SAFE-BioPharma Association.
NH-ISAC is a non-profit, member-driven organization offering healthcare stakeholders a trusted community and forum for sharing cyber and physical threat indicators, vulnerabilities, best practices and mitigation strategies. [www.nhisac.org]